Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-10.57	184.99	206.85
Graham Fair Price	-5.31	356691.82	376688.72
PEG	3161.44	-0.50	0.02
Price/Book	18.65	0.95	0.80
Price/Cash Flow	-28.07	10.05	13.97
Prices/Earnings	39.82	6.47	4.62
Price/Sales	33.36	3.14	2.35
Price/FCF	-28.07	10.05	13.97
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	9.78	1.10	1.00
Operating Margin	-4.65	0.16	0.16
ROA	-15.15	< 0.005	< 0.005
ROE	0.04	0.04	-15.14
ROIC	0.05	0.04	-18.99
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.07	< 0.005	10940.26
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	1.10	-0.13	-88.35
EPS QOQ	3.01	-0.13	-95.71
FCF QOQ	-0.12	0.70	477.54
Revenue QOQ	0.11	-0.09	-20.27
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	-0.10	-0.07	31.37
Quick Ratio	0.04	3.64	9851.50
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	382449.65	393875.94	2.99
Cash	44095.52	45370.18	2.89
Capex	-184.73	451.99	144.67
Free Cash Flow	21839.11	37028.91	69.55
Revenue	129543.32	118472.97	-8.55
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.06	3.64	6250.58
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-12.09	-7.63	36.94
Naive Interpretation	Member

06 - Financial Health · Bad

Rating